|
MARCH8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.46749962076842E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.13550313385736E-11 |
| Normal-vs-Stage2 |
9.67389999999568E-05 |
| Normal-vs-Stage3 |
2.406900E-04 |
| Normal-vs-Stage4 |
9.859100E-03 |
| Stage1-vs-Stage2 |
3.191200E-01 |
| Stage1-vs-Stage3 |
2.723600E-01 |
| Stage1-vs-Stage4 |
8.751800E-01 |
| Stage2-vs-Stage3 |
9.872800E-01 |
| Stage2-vs-Stage4 |
6.022800E-01 |
| Stage3-vs-Stage4 |
6.312200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8484003216912E-10 |
| Normal-vs-AfricanAmerican |
3.24299999965305E-07 |
| Normal-vs-Asian |
1.898280E-03 |
| Caucasian-vs-AfricanAmerican |
5.555400E-01 |
| Caucasian-vs-Asian |
9.156200E-01 |
| AfricanAmerican-vs-Asian |
9.206400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63979940737136E-12 |
| Normal-vs-Female |
8.875300E-03 |
| Male-vs-Female |
2.249800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.44459999998448E-06 |
| Normal-vs-Extreme_Weight |
1.62703184258817E-12 |
| Normal-vs-Obese |
1.29460000053427E-07 |
| Normal-vs-Extreme_Obese |
3.61570000000366E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.299800E-02 |
| Normal_Weight-vs-Obese |
6.140000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.604000E-01 |
| Extreme_Weight-vs-Obese |
3.083400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.832400E-01 |
| Obese-vs-Extreme_Obese |
4.738600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.558200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.80569999747627E-08 |
| Normal-vs-Age(61-80Yrs) |
1.71319625152933E-11 |
| Normal-vs-Age(81-100Yrs) |
4.44929999954269E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.879600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.038770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.268750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.264100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.211360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.969600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.81155090928087E-12 |
| Normal-VS-Type2 PRCC |
3.68120000004968E-06 |
| Normal-VS-KIRP CIMP |
2.068800E-01 |
| Normal-VS-Unclassified PRCC |
4.248000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.604310E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.253870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.339600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.928600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.704000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.017600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28039997995921E-09 |
| Normal-vs-N1 |
2.722400E-03 |
| Normal-vs-N2 |
3.625900E-02 |
| N0-vs-N1 |
1.568980E-01 |
| N0-vs-N2 |
5.170400E-01 |
| N1-vs-N2 |
9.621800E-01 |
|
|
